Can Pharmakogenetik Medicheck help with menopause?

Pharmacogenetics can theoretically help personalize medications used during menopause, such as hormone replacement therapy (HRT) or antidepressants for hot flashes. Variants in genes like CYP1A2, CYP2C19, and CYP2D6 affect estrogen and progestin metabolism. However, evidence for routine clinical use in menopause is limited. Most studies are mechanistic or observational; large randomized trials are lacking. Menopause symptoms are complex and influenced by lifestyle, psychology, and hormones. A DNA test like MyBody-X is marketed for metabolism and sports, not specifically for menopause. While pharmacogenetic insights may guide dosing or choice of HRT, they are not a standalone solution. Caveat: overinterpretation can lead to unnecessary anxiety or false reassurance. Evidence: mixed – plausible biological links exist, but human outcome data are insufficient to recommend universal testing.